Susceptibility of Rifampicin-Isoniazid Resistant Mycobacterium Tuberculosis Isolates Against Levofloxacin
<p><strong>Background: </strong>Tuberculosis (TB) is a high burden disease in Indonesia with multidrug-resistant (MDR) TB incidence started to increase. Treatment success of MDR-TB globally was low in number than it was targeted which was especially caused by fluoroquinolone resist...
Main Authors: | A. H. Kurniawan, N. M. Mertaniasih, S. Soedarsono |
---|---|
Format: | Article |
Language: | English |
Published: |
DiscoverSys
2016-01-01
|
Series: | Bali Medical Journal |
Subjects: | |
Online Access: | https://balimedicaljournal.org/index.php/bmj/article/view/184 |
Similar Items
-
Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01) -
Second-line drug susceptibilities of multidrug- and rifampicin-resistant Mycobacterium tuberculosis isolates in Delhi
by: Zeeshan Sidiq, et al.
Published: (2019-01-01) -
Validation of the GenoType® MTBDRplus Ver 2.0 assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates at UZCHS-CTRC TB research laboratory
by: Stephen Stephen, et al.
Published: (2019-01-01) -
Mutations in Mycobacterium tuberculosis Isolates with Discordant Results for Drug-Susceptibility Testing in Peru
by: Solari, L., et al.
Published: (2020) -
Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
by: James B. Whitney, et al.
Published: (2002-12-01)